Cargando…

Glucose-activatable insulin delivery with charge-conversional polyelectrolyte multilayers for diabetes care

One of the most effective treatments for diabetes is to design a glucose-regulated insulin (INS) delivery system that could adjust the INS release time and rate to reduce diabetes-related complications. Here, mixed multiple layer-by-layer (mmLbL)-INS microspheres were developed for glucose-mediated...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yanguang, Wang, Xiangqian, Yuan, Xiaopeng, Zhu, Qiwei, Chen, Shusen, Xia, Donglin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557070/
https://www.ncbi.nlm.nih.gov/pubmed/36246353
http://dx.doi.org/10.3389/fbioe.2022.996763
_version_ 1784807219891535872
author Yang, Yanguang
Wang, Xiangqian
Yuan, Xiaopeng
Zhu, Qiwei
Chen, Shusen
Xia, Donglin
author_facet Yang, Yanguang
Wang, Xiangqian
Yuan, Xiaopeng
Zhu, Qiwei
Chen, Shusen
Xia, Donglin
author_sort Yang, Yanguang
collection PubMed
description One of the most effective treatments for diabetes is to design a glucose-regulated insulin (INS) delivery system that could adjust the INS release time and rate to reduce diabetes-related complications. Here, mixed multiple layer-by-layer (mmLbL)-INS microspheres were developed for glucose-mediated INS release and an enhanced hypoglycemic effect for diabetes care. To achieve ultrafast glucose-activated INS release, glucose oxidase (GOx) was assembled with a positively charged polymer and modified on INS LbL. The mmLbL-INS microspheres were constructed with one, two, and four layers of the polyelectrolyte LbL assembly at a ratio of 1:1:1. Under hyperglycemia, GOx converts a change in the hyperglycemic environment to a pH stimulus, thus providing sufficient hydrogen ion. The accumulated hydrogen ion starts LbL charge shifting, and anionic polymers are converted to cationic polymers through hydrolytic cleavage of amine-functionalized side chains. The results of in vitro INS release suggested that glucose can modulate the mmLbL-INS microspheres in a pulsatile profile. In vivo studies validated that this formulation enhanced the hypoglycemic effect in STZ-induced diabetic rats within 2 h of subcutaneous administration and facilitated stabilization of blood glucose levels for up to 2 days. This glucose-activatable LbL microsphere system could serve as a powerful tool for constructing a precisely controlled release system.
format Online
Article
Text
id pubmed-9557070
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95570702022-10-14 Glucose-activatable insulin delivery with charge-conversional polyelectrolyte multilayers for diabetes care Yang, Yanguang Wang, Xiangqian Yuan, Xiaopeng Zhu, Qiwei Chen, Shusen Xia, Donglin Front Bioeng Biotechnol Bioengineering and Biotechnology One of the most effective treatments for diabetes is to design a glucose-regulated insulin (INS) delivery system that could adjust the INS release time and rate to reduce diabetes-related complications. Here, mixed multiple layer-by-layer (mmLbL)-INS microspheres were developed for glucose-mediated INS release and an enhanced hypoglycemic effect for diabetes care. To achieve ultrafast glucose-activated INS release, glucose oxidase (GOx) was assembled with a positively charged polymer and modified on INS LbL. The mmLbL-INS microspheres were constructed with one, two, and four layers of the polyelectrolyte LbL assembly at a ratio of 1:1:1. Under hyperglycemia, GOx converts a change in the hyperglycemic environment to a pH stimulus, thus providing sufficient hydrogen ion. The accumulated hydrogen ion starts LbL charge shifting, and anionic polymers are converted to cationic polymers through hydrolytic cleavage of amine-functionalized side chains. The results of in vitro INS release suggested that glucose can modulate the mmLbL-INS microspheres in a pulsatile profile. In vivo studies validated that this formulation enhanced the hypoglycemic effect in STZ-induced diabetic rats within 2 h of subcutaneous administration and facilitated stabilization of blood glucose levels for up to 2 days. This glucose-activatable LbL microsphere system could serve as a powerful tool for constructing a precisely controlled release system. Frontiers Media S.A. 2022-09-29 /pmc/articles/PMC9557070/ /pubmed/36246353 http://dx.doi.org/10.3389/fbioe.2022.996763 Text en Copyright © 2022 Yang, Wang, Yuan, Zhu, Chen and Xia. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
Yang, Yanguang
Wang, Xiangqian
Yuan, Xiaopeng
Zhu, Qiwei
Chen, Shusen
Xia, Donglin
Glucose-activatable insulin delivery with charge-conversional polyelectrolyte multilayers for diabetes care
title Glucose-activatable insulin delivery with charge-conversional polyelectrolyte multilayers for diabetes care
title_full Glucose-activatable insulin delivery with charge-conversional polyelectrolyte multilayers for diabetes care
title_fullStr Glucose-activatable insulin delivery with charge-conversional polyelectrolyte multilayers for diabetes care
title_full_unstemmed Glucose-activatable insulin delivery with charge-conversional polyelectrolyte multilayers for diabetes care
title_short Glucose-activatable insulin delivery with charge-conversional polyelectrolyte multilayers for diabetes care
title_sort glucose-activatable insulin delivery with charge-conversional polyelectrolyte multilayers for diabetes care
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557070/
https://www.ncbi.nlm.nih.gov/pubmed/36246353
http://dx.doi.org/10.3389/fbioe.2022.996763
work_keys_str_mv AT yangyanguang glucoseactivatableinsulindeliverywithchargeconversionalpolyelectrolytemultilayersfordiabetescare
AT wangxiangqian glucoseactivatableinsulindeliverywithchargeconversionalpolyelectrolytemultilayersfordiabetescare
AT yuanxiaopeng glucoseactivatableinsulindeliverywithchargeconversionalpolyelectrolytemultilayersfordiabetescare
AT zhuqiwei glucoseactivatableinsulindeliverywithchargeconversionalpolyelectrolytemultilayersfordiabetescare
AT chenshusen glucoseactivatableinsulindeliverywithchargeconversionalpolyelectrolytemultilayersfordiabetescare
AT xiadonglin glucoseactivatableinsulindeliverywithchargeconversionalpolyelectrolytemultilayersfordiabetescare